Cost-power of employing Alzheimer’s disease biomarkers inside the cerebrospinal fluid so you can predict progression off lightweight cognitive impairment to help you alzhiemer’s disease
Cost-power of employing Alzheimer’s disease biomarkers inside the cerebrospinal fluid so you can predict progression off lightweight cognitive impairment to help you alzhiemer’s disease L. H., Wimo, A great., Dodel, R., Kramberger, M. Grams., Visser, P. J., Molinuevo, J. L., mais aussi al. (2017). J. Alzheimers Dis. sixty, 1477–1487. doi: Read More